NIH nhlbi laboratory of regenerative therapies for inherited blood disorders requires zetasizer advance series - lab (red label) in order to characterize biophysical parameters of lipid nanoparticles.…
Ended Awarded Last action
- Contract number
- 75N92023F00178
- Awardee
-
Samyak Solutions, Inc. UEI WYU3YN2K79X5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $54,858
Award facts
- Contract value 100% obligated
- $54,858.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Centreville, VA 20121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $910 | |
| Original award | $53,949 |
About this award
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Samyak Solutions, Inc., a small, minority-owned business based in Centreville, Virginia. The $54,858.22 firm fixed-price delivery order is to provide a Zetasizer Advance Series - Lab (Red Label) instrument to the NHLBI Laboratory of Regenerative Therapies for Inherited Blood Disorders, in order to characterize the biophysical parameters of lipid nanoparticles.
Samyak Solutions is an 8(a) Program Participant, Economically Disadvantaged Women-Owned Small Business (EDWOSB), Women-Owned Small Business (WOSB), and HUBZone firm that specializes in providing scientific instruments, laboratory equipment, and related services to various federal agencies. This award was made under the General Services Administration's Multiple Award Schedule (MAS) contract vehicle, and the company holds two significant federal Indefinite Delivery Vehicles (IDVs) with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense and the NIH Office of Logistics and Acquisition Operations.
Description
NIH nhlbi laboratory of regenerative therapies for inherited blood disorders requires zetasizer advance series - lab (red label) in order to characterize biophysical parameters of lipid nanoparticles. [23-016363]
Quick answers
Who was awarded contract 75N92023F00178?
75N92023F00178 was awarded to Samyak Solutions, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 8, 2023.
How much is contract 75N92023F00178 worth?
The government has obligated $54,858 on 75N92023F00178.
Is contract 75N92023F00178 an order under another contract?
Yes. 75N92023F00178 is a delivery order under GS07F052BA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N92023F00178 competed?
The extent of competition for 75N92023F00178 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award